GlassScriptPhysician profile
Thomas A Masterson
NPI 1629496435
$32,583.43
in general payments reported to CMS, 2019-2025
17 companies · $1,895 in 2025
The $1,895 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,794 · 2020: $993 · 2021: $1,049 · 2022: $14K · 2023: $10K · 2024: $1,150 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,240 · Food and Beverage: $4,158 · Travel and Lodging: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,240.00 |
| Food and Beverage | $4,158.46 |
| Travel and Lodging | $1,112.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $19,663.84 | 2019-2024 | Xiaflex |
| Boston Scientific Corporation | $6,523.10 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $3,588.10 | 2019-2025 | Titan, Speedicath |
| Endo USA, INC. | $564.84 | 2024-2025 | Xiaflex |
| Aytu Biopharma, INC. | $451.04 | 2019 | |
| Northgate Technologies, INC. | $250.00 | 2020 | |
| Acerus Pharmaceuticals Corporation | $241.36 | 2020-2022 | |
| Antares Pharma, INC. | $217.12 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Myriad Genetic Laboratories, INC. | $213.03 | 2022-2023 | Prolaris, Myrisk |
| Procept Biorobotics Corporation | $204.00 | 2024 | Aquabeam System |
| Axonics, INC. | $140.80 | 2022 | |
| Biotissue Holdings INC. | $117.06 | 2025 | |
| Greenwich Biosciences, INC. | $107.12 | 2019 | |
| Rigicon,INC. | $104.97 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Valencia Technologies Corporation | $100.08 | 2025 | Ecoin Device Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $62.27 | 2020 | |
| Ambu INC. | $34.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Masterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.